$CDTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cidara Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cidara Therapeutics, Inc.. Get notifications about new insider transactions in Cidara Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2021 | CDTX | Cidara Therapeutic ... | BURGESS DANIEL D | Director | Option Exercise | A | 1.92 | 17,500 | 33,600 | 17,500 | |
| Apr 05 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Sell | S | 2.66 | 1,177 | 3,131 | 7,764 | 8.9 K to 7.8 K (-13.16 %) |
| Apr 05 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Grant | A | 0.00 | 2,800 | 0 | 8,941 | 6.1 K to 8.9 K (+45.60 %) |
| Apr 05 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Sell | S | 2.06 | 824 | 1,697 | 6,141 | 7 K to 6.1 K (-11.83 %) |
| Apr 05 2021 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Grant | A | 0.00 | 700 | 0 | 82,031 | 81.3 K to 82 K (+0.86 %) |
| Apr 05 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Grant | A | 0.00 | 10,000 | 0 | 361,878 | 351.9 K to 361.9 K (+2.84 %) |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.55 | 525,000 | 1,338,750 | 525,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | A | 2.55 | 130,000 | 331,500 | 130,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.55 | 150,000 | 382,500 | 150,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.55 | 120,000 | 306,000 | 120,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.55 | 145,000 | 369,750 | 145,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.55 | 525,000 | 1,338,750 | 525,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | A | 2.55 | 130,000 | 331,500 | 130,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Option Exercise | A | 2.55 | 135,000 | 344,250 | 135,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.55 | 150,000 | 382,500 | 150,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.55 | 120,000 | 306,000 | 120,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.55 | 145,000 | 369,750 | 145,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Option Exercise | A | 2.55 | 135,000 | 344,250 | 135,000 | |
| Jan 25 2021 | CDTX | Cidara Therapeutic ... | Canale-Theakston Carin | Director | Option Exercise | A | 2.51 | 35,000 | 87,850 | 35,000 | |
| Jan 25 2021 | CDTX | Cidara Therapeutic ... | Bassler Bonnie L | Director | Option Exercise | A | 2.51 | 35,000 | 87,850 | 35,000 | |
| Nov 12 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 2.00 | 50,000 | 100,015 | 347,878 | 297.9 K to 347.9 K (+16.79 %) |
| Nov 12 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Buy | P | 2.01 | 50,000 | 100,720 | 50,000 | 0 to 50 K |
| Jun 25 2020 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Option Exercise | A | 3.97 | 17,500 | 69,475 | 17,500 | ||
| Jun 25 2020 | CDTX | Cidara Therapeutic ... | Mineo Chrysa | Option Exercise | A | 3.97 | 17,500 | 69,475 | 17,500 | ||
| Jun 25 2020 | CDTX | Cidara Therapeutic ... | Gollaher David L | Option Exercise | A | 3.97 | 17,500 | 69,475 | 17,500 | ||
| Jun 25 2020 | CDTX | Cidara Therapeutic ... | Franson Timothy R | Option Exercise | A | 3.97 | 17,500 | 69,475 | 17,500 | ||
| Jun 25 2020 | CDTX | Cidara Therapeutic ... | BURGESS DANIEL D | Option Exercise | A | 3.97 | 17,500 | 69,475 | 17,500 | ||
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 1.98 | 115,000 | 227,700 | 115,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 1.98 | 145,000 | 287,100 | 145,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 1.98 | 90,000 | 178,200 | 90,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Option Exercise | A | 1.98 | 90,000 | 178,200 | 90,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 1.98 | 330,000 | 653,400 | 330,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | M | 1.98 | 110,000 | 217,800 | 110,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 61,891 | 36.9 K to 61.9 K (+67.77 %) |
| Feb 11 2020 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | X | 2.51 | 6,115 | 15,349 | 0 | |
| Feb 11 2020 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | X | 2.51 | 4,594 | 11,531 | 0 | |
| Feb 11 2020 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Buy | X | 2.51 | 6,115 | 15,349 | 73,331 | 67.2 K to 73.3 K (+9.10 %) |
| Feb 11 2020 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Buy | X | 2.51 | 4,594 | 11,531 | 67,216 | 62.6 K to 67.2 K (+7.34 %) |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | X | 2.51 | 32,283 | 81,030 | 0 | |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | X | 2.51 | 7,558 | 18,971 | 0 | |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | X | 2.51 | 32,283 | 81,030 | 257,902 | 225.6 K to 257.9 K (+14.31 %) |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | X | 2.51 | 7,558 | 18,971 | 293,878 | 286.3 K to 293.9 K (+2.64 %) |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | X | 2.51 | 6,891 | 17,296 | 0 | |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Buy | X | 2.51 | 6,891 | 17,296 | 211,891 | 205 K to 211.9 K (+3.36 %) |
| Jan 06 2020 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Sell | S | 3.86 | 834 | 3,219 | 6,965 | 7.8 K to 7 K (-10.69 %) |
| Jan 06 2020 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Sell | S | 3.42 | 2,340 | 8,003 | 51,248 | 53.6 K to 51.2 K (-4.37 %) |
| Jan 06 2020 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Sell | S | 3.42 | 2,340 | 8,003 | 53,532 | 55.9 K to 53.5 K (-4.19 %) |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.45 | 4,075 | 9,984 | 4,075 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.45 | 32,592 | 79,850 | 32,592 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | D | 7.80 | 55,000 | 429,000 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.45 | 13,333 | 32,666 | 13,333 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | D | 11.11 | 20,000 | 222,200 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.45 | 3,333 | 8,166 | 3,333 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | D | 9.89 | 5,000 | 49,450 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.45 | 12,667 | 31,034 | 12,667 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | D | 13.62 | 19,000 | 258,780 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.45 | 4,074 | 9,981 | 4,074 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.45 | 32,592 | 79,850 | 32,592 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | D | 7.80 | 55,000 | 429,000 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.45 | 33,333 | 81,666 | 33,333 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | D | 9.89 | 50,000 | 494,500 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.45 | 17,125 | 41,956 | 17,125 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | D | 6.86 | 25,688 | 176,220 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.45 | 3,704 | 9,075 | 3,704 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.45 | 29,629 | 72,591 | 29,629 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | D | 7.80 | 50,000 | 390,000 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.45 | 9,721 | 23,816 | 9,721 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.45 | 56,945 | 139,515 | 56,945 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | D | 10.45 | 100,000 | 1,045,000 | 0 | |
| Oct 03 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Sell | S | 1.88 | 3,295 | 6,195 | 55,872 | 59.2 K to 55.9 K (-5.57 %) |
| Oct 03 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Sell | S | 1.98 | 7,284 | 14,422 | 49,588 | 56.9 K to 49.6 K (-12.81 %) |
| Oct 01 2019 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Sell | S | 1.86 | 1,001 | 1,862 | 7,799 | 8.8 K to 7.8 K (-11.37 %) |
| Sep 26 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 1.91 | 52,500 | 100,102 | 225,619 | 173.1 K to 225.6 K (+30.33 %) |
| Sep 26 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 1.91 | 52,500 | 100,102 | 225,619 | 173.1 K to 225.6 K (+30.33 %) |
| Sep 26 2019 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Buy | P | 1.91 | 30,000 | 57,240 | 205,000 | 175 K to 205 K (+17.14 %) |
| Sep 26 2019 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Buy | P | 1.91 | 30,000 | 57,240 | 205,000 | 175 K to 205 K (+17.14 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | M | 0.00 | 10,000 | 0 | 50,000 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Grant | A | 0.00 | 10,000 | 0 | 282,320 | 272.3 K to 282.3 K (+3.67 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,400 | 0 | 12,600 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,500 | 0 | 22,500 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Grant | A | 0.00 | 1,400 | 0 | 58,622 | 57.2 K to 58.6 K (+2.45 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Grant | A | 0.00 | 2,500 | 0 | 57,222 | 54.7 K to 57.2 K (+4.57 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Option Exercise | M | 0.00 | 2,800 | 0 | 11,200 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Grant | A | 0.00 | 2,800 | 0 | 8,800 | 6 K to 8.8 K (+46.67 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | M | 0.00 | 4,900 | 0 | 9,100 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | M | 0.00 | 17,500 | 0 | 7,500 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Grant | A | 0.00 | 4,900 | 0 | 56,872 | 52 K to 56.9 K (+9.43 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Grant | A | 0.00 | 17,500 | 0 | 51,972 | 34.5 K to 52 K (+50.77 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,100 | 0 | 11,900 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,500 | 0 | 17,500 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Grant | A | 0.00 | 2,100 | 0 | 59,167 | 57.1 K to 59.2 K (+3.68 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Grant | A | 0.00 | 7,500 | 0 | 57,067 | 49.6 K to 57.1 K (+15.13 %) |
| Jun 27 2019 | CDTX | Cidara Therapeutic ... | Gollaher David L | Director | Option Exercise | A | 1.60 | 11,000 | 17,600 | 11,000 | |
| Jun 27 2019 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Director | Option Exercise | A | 1.60 | 11,000 | 17,600 | 11,000 | |
| Jun 27 2019 | CDTX | Cidara Therapeutic ... | Franson Timothy R | Director | Option Exercise | A | 1.60 | 11,000 | 17,600 | 11,000 | |
| Jun 27 2019 | CDTX | Cidara Therapeutic ... | Mineo Chrysa | Director | Option Exercise | A | 1.60 | 11,000 | 17,600 | 11,000 | |
| Jun 27 2019 | CDTX | Cidara Therapeutic ... | BURGESS DANIEL D | Director | Option Exercise | A | 1.60 | 11,000 | 17,600 | 11,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.61 | 265,000 | 691,650 | 265,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Option Exercise | A | 2.61 | 65,000 | 169,650 | 65,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.61 | 77,000 | 200,970 | 77,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.61 | 77,000 | 200,970 | 77,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.61 | 65,000 | 169,650 | 65,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.61 | 265,000 | 691,650 | 265,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Option Exercise | A | 2.61 | 65,000 | 169,650 | 65,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.61 | 77,000 | 200,970 | 77,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.61 | 77,000 | 200,970 | 77,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.61 | 65,000 | 169,650 | 65,000 | |
| Mar 13 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Gift | G | 0.00 | 10,670 | 0 | 15,709 | 5 K to 15.7 K (+211.75 %) |
| Mar 13 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Gift | G | 0.00 | 21,340 | 0 | 173,119 | 194.5 K to 173.1 K (-10.97 %) |
| Mar 08 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Sell | S | 2.44 | 2,300 | 5,612 | 30,472 | 32.8 K to 30.5 K (-7.02 %) |
| Mar 08 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Sell | S | 2.55 | 2,240 | 5,714 | 49,567 | 51.8 K to 49.6 K (-4.32 %) |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | M | 0.00 | 14,000 | 0 | 14,000 | |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Grant | A | 0.00 | 6,000 | 0 | 32,772 | 26.8 K to 32.8 K (+22.41 %) |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 14,000 | 0 | 14,000 | |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 50,722 | 44.7 K to 50.7 K (+13.42 %) |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | M | 0.00 | 60,000 | 0 | 60,000 | |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Option Exercise | M | 0.00 | 14,000 | 0 | 14,000 | |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | M | 0.00 | 14,000 | 0 | 14,000 | |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Grant | A | 0.00 | 6,000 | 0 | 51,807 | 45.8 K to 51.8 K (+13.10 %) |
| Dec 04 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Gift | G | 0.00 | 4,619 | 0 | 5,039 | 420 to 5 K (+1,099.76 %) |
| Dec 04 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Gift | G | 0.00 | 9,238 | 0 | 194,459 | 203.7 K to 194.5 K (-4.54 %) |
| Dec 04 2018 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | A | 3.62 | 175,000 | 633,500 | 175,000 | |
| Sep 18 2018 | CDTX | Cidara Therapeutic ... | Johnson Brady | Dir. of Finance & C ... | Option Exercise | A | 4.25 | 4,000 | 17,000 | 4,000 | |
| Sep 12 2018 | CDTX | Cidara Therapeutic ... | Gollaher David L | Director | Option Exercise | A | 4.15 | 20,000 | 83,000 | 20,000 | |
| Jun 15 2018 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
| Jun 15 2018 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
| Jun 15 2018 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
| Jun 15 2018 | CDTX | Cidara Therapeutic ... | Mineo Chrysa | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
| Jun 15 2018 | CDTX | Cidara Therapeutic ... | Franson Timothy R | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
| Jun 15 2018 | CDTX | Cidara Therapeutic ... | BURGESS DANIEL D | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
| May 24 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 6.81 | 250,000 | 1,702,500 | 250,000 | |
| May 24 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 4.70 | 212,766 | 1,000,000 | 268,320 | 55.6 K to 268.3 K (+382.99 %) |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 4.00 | 235,000 | 940,000 | 235,000 | |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 4.00 | 70,000 | 280,000 | 70,000 | |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 4.00 | 70,000 | 280,000 | 70,000 | |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 4.00 | 72,000 | 288,000 | 72,000 | |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 4.00 | 72,000 | 288,000 | 72,000 | |
| Mar 01 2018 | CDTX | Cidara Therapeutic ... | Mineo Chrysa | Director | Option Exercise | A | 7.10 | 20,000 | 142,000 | 20,000 | |
| Nov 16 2017 | CDTX | Cidara Therapeutic ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 7.57 | 60,000 | 453,966 | 2,295,272 | 2.2 M to 2.3 M (+2.68 %) |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Grant | A | 0.00 | 15,000 | 0 | 20,421 | 5.4 K to 20.4 K (+276.70 %) |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Grant | A | 0.00 | 15,000 | 0 | 40,695 | 25.7 K to 40.7 K (+58.38 %) |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Onaitis Matthew | Gnrl Counsel, CFO & ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Onaitis Matthew | Gnrl Counsel, CFO & ... | Grant | A | 0.00 | 15,000 | 0 | 15,872 | 872 to 15.9 K (+1,720.18 %) |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Wilson Marc | Chief Accounting Of ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Wilson Marc | Chief Accounting Of ... | Grant | A | 0.00 | 5,000 | 0 | 10,356 | 5.4 K to 10.4 K (+93.35 %) |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Commercial Of ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Commercial Of ... | Grant | A | 0.00 | 15,000 | 0 | 45,807 | 30.8 K to 45.8 K (+48.69 %) |